All
Zactima Delays Advanced Lung Cancer Growth
An international phase III trial found the investigational lung cancer drug, Zactima (vandetanib), significantly slowed the time a patient’s advanced lung cancer progressed.
PARP Inhibitors Successful Against Hard-to-Treat Breast Cancers
A new class of drugs called PARP inhibitors is getting some serious attention in metastatic triple-negative breast cancers.
What's your exercise excuse?
How do we improve cancer clinical trial participation?
FDA approves the first cancer drug for dogs
Riding with Amazons
Study shows how to prevent rash from EGFR inhibitors
New site can help you find the financial assistance you need
Chemobrain research and attention growing
Olivia Newton-John wants to sing your song
Why aren't cancer docs talking to their patients about fertility?
A new test can predict risk of colon cancer recurrence
Ginger offers relief for chemo-related nausea
Patients with an unknown primary aren't getting the help they need
Fitness & Nutrition page debuts
Survivorship Care Plans
Are cancer survivors more likely to be unemployed?
Notes from Oz
Mom and teen home, but debate rages on...
Rash Decisions
Educational campaign launched to help nurses help patients who have treatment-related rash.
Treatment Updates From the Miami Breast Cancer Conference
For 25 years, surgical and medical oncologists have gathered in sunny Miami to discuss the latest strategies in breast cancer management.
Cancer Survivors Hit Harder with Job Losses
Experts offer advice to survivors after a study shows people with cancer have a higher risk of being unemployed than people without a history of cancer.
Finasteride Recommended to Prevent Prostate Cancer
Men may benefit from a drug that can reduce their risk of getting prostate cancer, according to new guidelines.
Voices: A Professional Opinion Given with Heart
Readers respond to questions posed by CURE.
Lung Cancer Patients May Soon Have New Drug Option
A drug temporarily withdrawn from the Food and Drug Administration for approval in non-small cell lung cancer will still likely get the green light when it's resubmitted.
International Melanoma Tissue Bank in the Works
A new organization aims to strike back at melanoma by developing the first-ever international melanoma tissue bank.
Kidney Cancer Expert Shares Insight on New Therapies
New therapies are making headway in a difficult-to-treat cancer.
Meeting Tackles Topics for Young Breast Cancer Survivors
The 8th Annual Conference for Young Women Affected by Breast Cancer welcomed women diagnosed with breast cancer at 40 or younger.
Blood Cancers Meeting Stresses the Importance of Clinical Trials
Clinical trials and other relevant topics were highlighted at the 2009 Texas Forum on Blood Cancers.
Job Hunting
Advice for survivors on looking for employmentÂ
